Invasive breast carcinoma - IARC

820. Falck J, Petrini JH, Williams BR, Lukas
J, Bartek J (2002). The DNA damagedependent
intra-S phase checkpoint is
regulated by parallel pathways. Nat Genet
30: 290-294.
821. Falconieri G, Della LD, Zanconati F,
Bittesini L (1997). Leiomyosarcoma of the
female breast: report of two new cases
and a review of the literature. Am J Clin
Pathol 108: 19-25.
822. Falkenberry SS, Steinhoff MM,
Gordinier M, Rappoport S, Gajewski W,
Granai CO (1996). Synchronous endometrioid
tumors of the ovary and endometrium.
A clinicopathologic study of 22 cases. J
Reprod Med 41: 713-718.
823. Fan LD, Zang HY, Zhang XS (1996).
Ovarian epidermoid cyst: report of eight
cases. Int J Gynecol Pathol 15: 69-71.
824. Fanburg-Smith JC, Meis-Kindblom
JM, Fante R, Kindblom LG (1998).
Malignant granular cell tumor of soft tissue:
diagnostic criteria and clinicopathologic
correlation. Am J Surg Pathol 22: 779-
794.
825. Fanning J, Lambert HC, Hale TM,
Morris PC, Schuerch C (1999). Paget's disease
of the vulva: prevalence of associated
vulvar adenocarcinoma, invasive
Paget's disease, and recurrence after surgical
excision. Am J Obstet Gynecol 180:
24-27.
826. Faquin WC, Fitzgerald JT, Lin MC,
Boynton KA, Muto MG, Mutter GL (2000).
Sporadic microsatellite instability is specific
to neoplastic and preneoplastic
endometrial tissues. Am J Clin Pathol 113:
576-582.
827. Farshid G, Moinfar F, Meredith DJ,
Peiterse S, Tavassoli FA (2001). Spindle
cell ductal carcinoma in situ. An unusual
variant of ductal intra-epithelial neoplasia
that simulates ductal hyperplasia or a
myoepithelial proliferation. Virchows Arch
439: 70-77.
828. Fastenberg NA, Martin RG, Buzdar AU,
Hortobagyi GN, Montague ED,
Blumenschein GR, Jessup JM (1985).
Management of inflammatory carcinoma
of the breast. A combined modality
approach. Am J Clin Oncol 8: 134-141.
829. Fathalla MF (1967). The occurrence of
granulosa and theca tumours in clinically
normal ovaries. A study of 25 cases. J
Obstet Gynaecol Br Commonw 74: 278-282.
830. Faul C, Kounelis S, Karasek K,
Papadaki H, Greeenberger J, Jones MW
(1996). Small cell carcinoma of the uterine
cervix: Overespression of p53, Bcl2, and
CD 44. Int J Gynecol Cancer 6: 369-375.
831. Faverly DR, Burgers L, Bult P, Holland
R (1994). Three dimensional imaging of
mammary ductal carcinoma in situ: clinical
implications. Semin Diagn Pathol 11: 193-
198.
832. Fawcett FJ, Kimbell NK (1971).
Phaeochromocytoma of the ovary. J
Obstet Gynaecol Br Commonw 78: 458-459.
833. Feakins RM, Lowe DG (1997). Basal
cell carcinoma of the vulva: a clinicopathologic
study of 45 cases. Int J Gynecol
Pathol 16: 319-324.
834. Fechner RE (1972). Infiltrating lobular
carcinoma without lobular carcinoma in
situ. Cancer 29: 1539-1545.
835. Fechner RE (1975). Histologic variants
of infiltrating lobular carcinoma of the
breast. Hum Pathol 6: 373-378.
836. Fechner RE, Mills SE (1990). Breast
Pathology Benign Proliferations, Atypias In
Situ Carcinomas. ASCP Press - American
Society of Clinical Pathologist: Chicago.
837. Feczko JD, Jentz DL, Roth LM (1996).
Adenoid cystic ovarian carcinoma compared
with other adenoid cystic carcinomas
of the female genital tract. M o d
Pathol 9: 413-417.
838. Feeley KM, Wells M (2001). Precursor
lesions of ovarian epithelial malignancy.
Histopathology 38: 87-95.
839. Fein DA, Fowble BL, Hanlon AL, Hooks
MA, Hoffman JP, Sigurdson ER, Jardines
LA, Eisenberg BL (1997). Identification of
women with T1-T2 breast cancer at low
risk of positive axillary nodes. J Surg
Oncol 65: 34-39.
840. Feinmesser M, Sulkes A, Morgenstern
S, Sulkes J, Stern S, Okon E (2000). HLA-DR
and beta 2 microglobulin expression in
medullary and atypical medullary carcinoma
of the breast: histopathologically similar
but biologically distinct entities. J Clin
Pathol 53: 286-291.
841. Feldman LD, Hortobagyi GN, Buzdar
AU, Ames FC, Blumenschein GR (1986).
Pathological assessment of response to
induction chemotherapy in breast cancer.
Cancer Res 46: 2578-2581.
842. Feltmate CM, Genest DR, Wise L,
Bernstein MR, Goldstein DP, Berkowitz RS
(2001). Placental site trophoblastic tumor:
a 17-year experience at the New England
Trophoblastic Disease Center. G y n e c o l
Oncol 82: 415-419.
843. Fenoglio C, Lattes R (1974). Sclerosing
papillary proliferations in the female
breast. A benign lesion often mistaken for
carcinoma. Cancer 33: 691-700.
844. Fentiman IS, Millis RR, Smith P, Ellul
JP, Lampejo O (1997). Mucoid breast carcinomas:
histology and prognosis. Br J
Cancer 75: 1061-1065.
845. Ferguson AW, Katabuchi H, Ronnett
BM, Cho KR (2001). Glial implants in
gliomatosis peritonei arise from normal tissue,
not from the associated teratoma. Am
J Pathol 159: 51-55.
846. Ferlay J, Bray F, Pisani P, Parkin DM
(2001). Globocan 2000. Cancer Incidence,
Mortality and Prevalence Worlwide.
IARCPress: Lyon.
847. Fernandez FA, Val-Bernal F, Garijo-
Ayensa F (1989). Mixed lipomas of the
uterus and the broad ligament. Appl Pathol
7: 70-71.
848. Feroze M, Aravindan KP, Thomas M
(1997). Mullerian adenosarcoma of the
uterine cervix. Indian J Cancer 34: 68-72.
849. Ferry JA, Scully RE (1988). "Adenoid
cystic" carcinoma and adenoid basal carcinoma
of the uterine cervix. A study of 28
cases. Am J Surg Pathol 12: 134-144.
850. Ferry JA, Scully RE (1990).
Mesonephric remnants, hyperplasia, and
neoplasia in the uterine cervix. A study of
49 cases. Am J Surg Pathol 14: 1100-1111.
851. Ferry JA, Young RH (1991). Malignant
lymphoma, pseudolymphoma, and
hematopoietic disorders of the female
genital tract. Pathol Annu 26 Pt 1: 227-263.
852. Ferry JA, Young RH, Engel G, Scully RE
(1994). Oxyphilic Sertoli cell tumor of the
ovary: a report of three cases, two in
patients with the Peutz-Jeghers syndrome.
Int J Gynecol Pathol 13: 259-266.
853. Fetsch JF, Laskin WB, Lefkowitz M,
Kindblom LG, Meis-Kindblom JM (1996).
Aggressive angiomyxoma: a clinicopathologic
study of 29 female patients. Cancer
78: 79-90.
854. Fetsch JF, Laskin WB, Tavassoli FA
(1997). Superficial angiomyxoma (cutaneous
myxoma): a clinicopathologic study
of 17 cases arising in the genital region. Int
J Gynecol Pathol 16: 325-334.
855. Feyrter F, Hartmann G (1963). Uber die
carcinoide Wuchsform des Carcinoma
mammae, insbesondere das Carcinoma
solidum (gelatinosum) mamma. Fradf Z
Pathol 73: 24-30.
856. Fiche M, Avet-Loiseau H, Maugard
CM, Sagan C, Heymann MF, Leblanc M,
Classe JM, Fumoleau P, Dravet F, Mahe M,
Dutrillaux B (2000). Gene amplifications
detected by fluorescence in situ hybridization
in pure intraductal breast carcinomas:
relation to morphology, cell proliferation
and expression of breast cancer-related
genes. Int J Cancer 89: 403-410.
857. Fina F, Romain S, Ouafik L, Palmari J,
Ben Ayed F, Benharkat S, Bonnier P,
Spyratos F, Foekens JA, Rose C, Buisson
M, Gerard H, Reymond MO, Seigneurin
JM, Martin PM (2001). Frequency and
genome load of Epstein-Barr virus in 509
breast cancers from different geographical
areas. Br J Cancer 84: 783-790.
858. Fingerland A (1938). Ganglioneuroma
of the cervix uteri. J Pathol Bacteriol 47:
631-634.
859. Fink D, Kubik-Huch RA, Wildermuth S
(2001). Juvenile granulosa cell tumor.
Abdom Imaging 26: 550-552.
860. Fink D, Nebel S, Aebi S, Zheng H, Kim
HK, Christen RD, Howell SB (1997).
Expression of the DNA mismatch repair
proteins hMLH1 and hPMS2 in normal
human tissues. Br J Cancer 76: 890-893.
861. Finkler NJ, Berkowitz RS, Driscoll SG,
Goldstein DP, Bernstein MR (1988). Clinical
experience with placental site trophoblas -
tic tumors at the New England
Trophoblastic Disease Center. O b s t e t
Gynecol 71: 854-857.
862. Finn WF, Javert CT (1949). Primary and
metastatic cancer of the fallopian tube.
Cancer 2: 803-814.
863. Fishel R (2001). The selection for mismatch
repair defects in hereditary nonpolyposis
colorectal cancer: revising the
mutator hypothesis. Cancer Res 61: 7369-
7374.
8 6 4 . Fishel R, Lescoe MK, Rao MR,
Copeland NG, Jenkins NA, Garber J, Kane
M, Kolodner R (1993). The human mutator
gene homolog MSH2 and its association
with hereditary nonpolyposis colon cancer.
Cell 75: 1027-1038.
865. Fisher B, Costantino JP, Wickerham
DL, Redmond CK, Kavanah M, Cronin WM,
Vogel V, Robidoux A, Dimitrov N, Atkins J,
Daly M, Wieand S, Tan-Chiu E, Ford L,
Wolmark N (1998). Tamoxifen for prevention
of breast cancer: report of the
National Surgical Adjuvant Breast and
Bowel Project P-1 Study. J Natl Cancer
Inst 90: 1371-1388.
8 6 6 . Fisher B, Dignam J, Wolmark N,
Wickerham DL, Fisher ER, Mamounas E,
Smith R, Begovic M, Dimitrov NV,
Margolese RG, Kardinal CG, Kavanah MT,
Fehrenbacher L, Oishi RH (1999).
Tamoxifen in treatment of intraductal
breast cancer: National Surgical Adjuvant
Breast and Bowel Project B-24 randomised
controlled trial. Lancet 353: 1993-
2000.
867. Fisher CJ, Hanby AM, Robinson L,
Millis RR (1992). Mammary hamartoma--a
review of 35 cases. Histopathology 20: 99-
106.
868. Fisher ER, Anderson S, Redmond C,
Fisher B (1993). Pathologic findings from
the National Surgical Adjuvant Breast
Project protocol B-06. 10-year pathologic
and clinical prognostic discriminants.
Cancer 71: 2507-2514.
8 6 9 . Fisher ER, Costantino J, Fisher B,
Palekar AS, Paik SM, Suarez CM, Wolmark
N (1996). Pathologic findings from the
National Surgical Adjuvant Breast Project
(NSABP) Protocol B-17. Five-year observations
concerning lobular carcinoma in situ.
Cancer 78: 1403-1416.
8 7 0 . Fisher ER, Costantino J, Fisher B,
Palekar AS, Redmond C, Mamounas E
(1995). Pathologic findings from the
National Surgical Adjuvant Breast Project
(NSABP) Protocol B-17. Intraductal carcinoma
(ductal carcinoma in situ). The
National Surgical Adjuvant Breast and
Bowel Project Collaborating Investigators.
Cancer 75: 1310-1319.
8 7 1 . Fisher ER, Costantino J, Fisher B,
Redmond C (1993). Pathologic findings
from the National Surgical Adjuvant Breast
Project (Protocol 4). Discriminants for 15-
year survival. National Surgical Adjuvant
Breast and Bowel Project Investigators.
Cancer 71: 2141-2150.
8 7 2 . Fisher ER, Fisher B, Sass R,
Wickerham L (1984). Pathologic findings
from the National Surgical Adjuvant Breast
Project (Protocol No. 4). XI. Bilateral breast
cancer. Cancer 54: 3002-3011.
8 7 3 . Fisher ER, Gregorio R, Kim WS,
Redmond C (1977). Lipid in invasive cancer
of the breast. Am J Clin Pathol 68: 558-561.
8 7 4 . Fisher ER, Gregorio RM, Fisher B,
Redmond C, Vellios F, Sommers SC (1975).
The pathology of invasive breast cancer. A
syllabus derived from findings of the
National Surgical Adjuvant Breast Project
(protocol no. 4). Cancer 36: 1-85.
875. Fisher ER, Gregorio RM, Redmond C,
Fisher B (1977). Tubulolobular invasive
breast cancer: a variant of lobular invasive
cancer. Hum Pathol 8: 679-683.
876. Fisher ER, Kenny JP, Sass R, Dimitrov
NV, Siderits RH, Fisher B (1990). Medullary
cancer of the breast revisited. B r e a s t
Cancer Res Treat 16: 215-229.
877. Fisher ER, Palekar AS, Gregorio RM,
Redmond C, Fisher B (1978). Pathological
findings from the National Surgical
Adjuvant Breast Project (Protocol No 4) IV.
Significance of tumour necrosis. H u m
Pathol 9: 523-530.
878. Fisher ER, Palekar AS, Gregorio RM,
Paulson JD (1983). Mucoepidermoid and
squamous cell carcinomas of breast with
reference to squamous metaplasia and
giant cell tumors. Am J Surg Pathol 7: 15-
27.
879. Fisher ER, Palekar AS, Redmond C,
Barton B, Fisher B (1980). Pathologic findings
from the National Surgical Adjuvant
Breast Project (protocol no. 4). VI. Invasive
papillary cancer. Am J Clin Pathol 73: 313-
322.
880. Fisher ER, Tavares J, Bulatao IS, Sass
R, Fisher B (1985). Glycogen-rich, clear cell
breast cancer: with comments concerning
other clear cell variants. Hum Pathol 16:
1085-1090.
881. Fisher PE, Estabrook A, Cohen MB
(1990). Fine needle aspiration biopsy of
intramammary neurilemoma. Acta Cytol 34:
35-37.
References 385